World Hypertension League: Its Scope, Purpose, and Impact in South Asia
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:2] [Pages No:55 - 56]
DOI: 10.5005/jp-journals-10043-0031 | Open Access | How to cite |
Abstract
Lackland DT, Ram CVS. World Hypertension League: Its Scope, Purpose, and Impact in South Asia. Hypertens J 2016;2(2):55-56.How to cite this article
Dietary Salt and Blood Pressure: Verdict is Clear, so why Any Debate?
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:3] [Pages No:57 - 59]
Keywords: Blood pressure,Cardiovascular disease,Conflict of interest,Diet,Hypertension,Nutrition,Public health,Salt,Sodium
DOI: 10.5005/jp-journals-10043-0032 | Open Access | How to cite |
Abstract
Campbell NRC, Cappuccio FP. Dietary Salt and Blood Pressure: Verdict is Clear, so why Any Debate? Hypertens J 2016;2(2):57-59.How to cite this article
Evaluation of Sympathetic Activity in Hypertension
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:5] [Pages No:60 - 64]
Keywords: Hypertension,Microneurography,Muscle sympathetic nerve activity,Norepinephrine spillover,Renal denervation,Sympathetic nerve activity
DOI: 10.5005/jp-journals-10043-0033 | Open Access | How to cite |
Abstract
Peri-Okonny PA, Vongpatanasin W. Evaluation of Sympathetic Activity in Hypertension. Hypertens J 2016;2(2):60-64.How to cite this article
Small Vessel Disease of the Brain and Stroke: Association with Clinic and Ambulatory Blood Pressure
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:9] [Pages No:65 - 73]
DOI: 10.5005/jp-journals-10043-0034 | Open Access | How to cite |
Abstract
Gupta P, White WB. Small Vessel Disease of the Brain and Stroke: Association with Clinic and Ambulatory Blood Pressure. Hypertens J 2016;2(2):65-73.How to cite this article
Sodium Glucose Cotransporter-2 Inhibitors in Clinical Practice: Impact beyond Glycemic Control
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:6] [Pages No:74 - 79]
DOI: 10.5005/jp-journals-10043-0035 | Open Access | How to cite |
Abstract
Rao NK, Kumar KMP. Sodium Glucose Cotransporter-2 Inhibitors in Clinical Practice: Impact beyond Glycemic Control. Hypertens J 2016;2(2):74-79.How to cite this article
Therapeutic Role of Beta-blockers in Hypertension: A Pragmatic Reappraisal
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:6] [Pages No:80 - 85]
DOI: 10.5005/jp-journals-10043-0036 | Open Access | How to cite |
Abstract
Kumar S. Therapeutic Role of Beta-blockers in Hypertension: A Pragmatic Reappraisal. Hypertens J 2016;2(2):80-85.How to cite this article
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:10] [Pages No:86 - 95]
DOI: 10.5005/jp-journals-10043-0037 | Open Access | How to cite |
Abstract
Nandwani A, Kher V. Renovascular Hypertension. Hypertens J 2016;2(2):86-95.How to cite this article
Severe Paroxysmal Hypertension: Pseudopheochromocytoma
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:7] [Pages No:96 - 102]
DOI: 10.5005/jp-journals-10043-0038 | Open Access | How to cite |
Abstract
Mann SJ. Severe Paroxysmal Hypertension: Pseudopheochromocytoma. Hypertens J 2016;2(2):96-102.How to cite this article
Fibromuscular Dysplasia of Renal Artery
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:2] [Pages No:103 - 104]
DOI: 10.5005/jp-journals-10043-0039 | Open Access | How to cite |
Abstract
Rao KS. Fibromuscular Dysplasia of Renal Artery. Hypertens J 2016;2(2):103-104.How to cite this article
Primary Hyperaldosteronism: Typical Clinical Manifestations
[Year:2016] [Month:April-June] [Volume:2] [Number:2] [Pages:3] [Pages No:105 - 107]
DOI: 10.5005/jp-journals-10043-0040 | Open Access | How to cite |
Abstract
Bharadiya AA, Karthik GS, Sharma DVSNL, Ram VS. Primary Hyperaldosteronism: Typical Clinical Manifestations. Hypertens J 2016;2(2):105-107.How to cite this article
© Jaypee Brothers Medical Publishers (P) LTD.
